Visit COVID-19 resources

[Skip to Content]

Eye Journal

Uveal melanoma: relatively rare but deadly cancer – (Eye Journal AOP)

Dec 02
2016

Uveal melanoma: relatively rare but deadly cancer Eye advance online publication, December 2 2016. doi:10.1038/eye.2016.275 Authors: S Kaliki & C L Shields

  • 2 December 2016

A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration – (Eye Journal AOP)

Nov 25
2016

A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration Eye advance online publication, November 25 2016. doi:10.1038/eye.2016.227 Authors: U Schmidt-Erfurth, S Klimscha, S M Waldstein & H Bogunović

  • 25 November 2016

Hyper-IL-6: a potent and efficacious stimulator of RGC regeneration – (Eye Journal AOP)

Nov 25
2016

Hyper-IL-6: a potent and efficacious stimulator of RGC regeneration Eye advance online publication, November 25 2016. doi:10.1038/eye.2016.234 Author: D Fischer

  • 25 November 2016

Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment – (Eye Journal AOP)

Nov 25
2016

Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment Eye advance online publication, November 25 2016. doi:10.1038/eye.2016.246 Authors: E Al Kahtani, Z Xu, S Al Rashaed, L Wu, A Mahale, J Tian, E B Abboud, N G Ghazi, I Kozak, V Gupta, J F

  • 25 November 2016

Fingolimod: therapeutic mechanisms and ocular adverse effects – (Eye Journal AOP)

Nov 25
2016

Fingolimod: therapeutic mechanisms and ocular adverse effects Eye advance online publication, November 25 2016. doi:10.1038/eye.2016.258 Authors: P Mandal, A Gupta, W Fusi-Rubiano, P A Keane & Y Yang

  • 25 November 2016